Ir al contenido principal
  • Iniciar sesión
    Bienvenido.
    Mi cuenta
    Cierre de sesión

Live Oak Bancshares, Inc. (LOB) Previsión de existencias 2025 - Predicción y análisis del precio de la IA

Live Oak Bancshares, Inc. (LOB) Previsión del precio de las acciones de AI y análisis de inversiones

Live Oak Bancshares, Inc. Gráfico de cotizaciones y análisis técnico

Loading Live Oak Bancshares, Inc. gráfico interactivo de cotizaciones y análisis técnico...

Live Oak Bancshares, Inc. (LOB) - Análisis exhaustivo de valores e investigación de inversiones

Deep dive into Live Oak Bancshares, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Live Oak Bancshares, Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

Para Live Oak Bancshares, Inc.: Live Oak Bancshares, Inc. operates in the Finance sector, making it an emerging small-cap investment.

Live Oak Bancshares, Inc. (Símbolo bursátil: LOB) es una empresa líder en el sector Finance. que opera específicamente en la industria State Commercial Banks..

La organización emplea a unos 600 profesionales en todo el mundo .

La empresa se ha consolidado como una oportunidad de inversión emergente con un gran potencial de crecimiento.

Understanding Financial Performance

Qué significan estas métricas: Key financial indicators showing Live Oak Bancshares, Inc.'s revenue scale, profitability, market value, and shareholder returns.

Cómo leerlos: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

Para Live Oak Bancshares, Inc.: With $407M in annual revenue and 35,6% net margin, the company demonstrates exceptional profitability.

Ingresos anuales: $407 millones generar un 35,6% margen de beneficio neto .

Capitalización bursátil: $1681 millones - Clasificado como inversión en pequeña capitalización con alto potencial de crecimiento.

Rentabilidad de los fondos propios (ROE): 24,9% - Excepcional eficiencia de la rentabilidad para el accionista, lo que indica gran eficacia de gestión.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Live Oak Bancshares, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

Para Live Oak Bancshares, Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Desbloquea las predicciones de IA Premium para acceder a nuestras previsiones avanzadas de aprendizaje automático para la acción Live Oak Bancshares, Inc., incluidos objetivos de precio a 7, 30 y 90 días con intervalos de confianza y evaluaciones de riesgo.

Understanding Market Position

What this analysis covers: Live Oak Bancshares, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

Para Live Oak Bancshares, Inc.: Strong free cash flow generation demonstrates developing operational efficiency.

Live Oak Bancshares, Inc. compite estratégicamente en el altamente dinámico State Commercial Banks mercado, representa una inversión emergente de pequeña capitalización con un potencial de crecimiento sustancial y capacidad de disrupción del mercado .

La empresa demuestra una sólida eficiencia operativa a través de una fuerte generación de flujo de caja libre de $51 millones anuales.

Live Oak Bancshares, Inc. (LOB) Análisis fundamental y datos sobre operaciones con información privilegiada (Informes financieros trimestrales)

Datos financieros trimestrales completos, tendencias de beneficios, transacciones con información privilegiada y participaciones institucionales de Live Oak Bancshares, Inc. análisis de valores.

Cargando Live Oak Bancshares, Inc. análisis fundamental exhaustivo y datos de información privilegiada...

Profundice en la salud financiera, las métricas de valoración y la eficiencia operativa de Live Oak Bancshares, Inc. para tomar decisiones de inversión informadas.

Comprender las métricas de valoración

Qué significan estas métricas: Las métricas de valoración ayudan a determinar si las acciones Live Oak Bancshares, Inc. tienen un precio justo en comparación con sus beneficios, activos y posición en el mercado.

Cómo leerlos: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

Para Live Oak Bancshares, Inc.: Con un PER de 29,98, el mercado valora muy positivamente las perspectivas de crecimiento.

P/E Ratio 29,98x
P/B Ratio 1,58x
Market Cap $1681M
Dividend Yield 0,33%
EPS $1,22
Valor contable/acción $23,11
Ingresos/Acciones $8,86
FCF/Acción $-10,66
Entender las métricas de rentabilidad

Qué significan estas métricas: Estos ratios miden la eficacia con la que Live Oak Bancshares, Inc. convierte los ingresos en beneficios y genera rentabilidad para los accionistas.

Cómo leerlos: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

Para Live Oak Bancshares, Inc.: Un ROE de 24,9% demuestra una excelente creación de valor para el accionista.

ROE 24,9%
ROA 1,9%
Net Margin 35,6%
EBT Margin 46,1%
Tax Rate 22,9%
Entender las métricas de salud financiera

Qué significan estas métricas: Estos ratios evalúan la capacidad de Live Oak Bancshares, Inc. para hacer frente a las obligaciones a corto plazo y gestionar eficazmente los niveles de endeudamiento.

Cómo leerlos: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

Para Live Oak Bancshares, Inc.:

D/E Ratio 0,24x
Financial Leverage 12,08x
Entender las métricas del flujo de caja

Qué significan estas métricas: Las métricas de flujo de caja revelan la capacidad de Live Oak Bancshares, Inc. para generar efectivo a partir de operaciones y financiar iniciativas de crecimiento.

Cómo leerlos: El flujo de caja operativo positivo es crucial. El flujo de caja libre muestra el dinero disponible para dividendos, recompras o inversiones.

Para Live Oak Bancshares, Inc.: Flujo de caja libre de $51M proporciona flexibilidad para el rendimiento de los accionistas y las inversiones de crecimiento.

Operating Cash Flow $74M
Free Cash Flow $51M
Capital Spending $-22M
FCF/Sales 11,2%
CapEx/Sales 4,9%
Entender las métricas de eficiencia operativa

Qué significan estas métricas: Estos ratios miden la eficacia con la que Live Oak Bancshares, Inc. utiliza sus activos y gestiona el capital circulante.

Cómo leerlos: Unos índices de rotación más elevados indican una utilización eficaz de los activos. Los periodos de cobro más cortos muestran una gestión eficaz del crédito.

Para Live Oak Bancshares, Inc.: Una rotación de activos de 0,05x sugiere un margen de mejora en utilización de activos.

Asset Turnover 0,05x
Fixed Assets Turnover 1,8x
Comprender los datos de los estados financieros

Qué significan estas métricas: Cifras clave de la cuenta de resultados y el balance de Live Oak Bancshares, Inc. que muestran los resultados financieros absolutos.

Cómo leerlos: Los ingresos muestran la escala empresarial, mientras que los márgenes indican la rentabilidad. Las partidas del balance revelan la estructura financiera.

Para Live Oak Bancshares, Inc.: Con unos ingresos anuales de 407M, Live Oak Bancshares, Inc. demuestra un tamaño empresarial sólido.

Cuenta de resultados ($ Millones)
Ingresos totales $407M
Gastos de venta, generales y administrativos $38M
Hechos destacados del balance (% Of Assets)
Cash & Short-term Investments 15%
Total Liabilities 92%
Short-term Debt 0%
Información sobre dividendos y accionistas
Dividends Per Share $0,12
Payout Ratio 3,3%
Shares Outstanding 46M
Métricas de crecimiento (interanual)
EPS Growth 5,2%

Última Live Oak Bancshares, Inc. Noticias y análisis bursátiles

Noticias de última hora, informes de analistas y actualizaciones del mercado que afectan a la cotización de Live Oak Bancshares, Inc. (LOB) y a las perspectivas de inversión.

, fuente: Seeking Alpha

WILMINGTON, N.C., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Live Oak Bancshares, Inc. (LOB) (“Live Oak” or the “Company”) announced the closing of its previously announced underwritten offering of 4,000,000 ...

, fuente: Morningstar

WILMINGTON, N.C., July 23, 2025 (GLOBE NEWSWIRE) -- Live Oak Bancshares, Inc. (NYSE: LOB) (“Live Oak” or “the Company”) today reported second quarter of 2025 net income attributable to the Company of ...

, fuente: Business Insider

WILMINGTON, N.C., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Live Oak Bancshares, Inc. (NYSE: LOB) (“Live Oak” or “the Company”) today reported third quarter of 2024 net income of $13.0 million, or $0.28 per ...

, fuente: Morningstar

WILMINGTON, N.C., April 23, 2025 (GLOBE NEWSWIRE) -- Live Oak Bancshares, Inc. (NYSE: LOB) (“Live Oak” or “the Company”) today reported first quarter of 2025 net income attributable to the Company of ...

, fuente: Eagle-Tribune

WILMINGTON, N.C., July 28, 2025 (GLOBE NEWSWIRE) -- Live Oak Bancshares, Inc. (NYSE: LOB) (“Live Oak” or the “Company”) announced the pricing of an underwritten offering of 4,000,000 depositary shares ...

Live Oak Bancshares, Inc. Competidores y análisis de pares - Finance Sector

Análisis comparativo de Live Oak Bancshares, Inc. frente a sus homólogos y competidores del sector Finance, con previsiones basadas en IA y métricas financieras clave.

Empresa Código bursátil Previsión de IA a 90 días Capitalización bursátil (M USD) Ratio PER Ratio P/B
ABCB Unlock Forecast - 30 Days FREE Trial $5126M 13,1x 1,3x
ACNB Unlock Forecast - 30 Days FREE Trial $471M 18,7x 1,2x
ALLY Unlock Forecast - 30 Days FREE Trial $12250M 15,3x 0,9x
AMAL Unlock Forecast - 30 Days FREE Trial $1010M 10,8x 1,3x
ASB Unlock Forecast - 30 Days FREE Trial $4371M 31,4x 0,9x
ASBA Unlock Forecast - 30 Days FREE Trial $4154M 29,8x 0,9x
ASB-PE Unlock Forecast - 30 Days FREE Trial $3661M 26,3x 0,8x
ASB-PF Unlock Forecast - 30 Days FREE Trial $3552M 25,5x 0,7x
AUB Unlock Forecast - 30 Days FREE Trial $5019M 24,6x 1,0x
AUBN Unlock Forecast - 30 Days FREE Trial $77M 12,6x 1,1x
AUB-PA Unlock Forecast - 30 Days FREE Trial $3541M 17,4x 0,7x
BAFN Unlock Forecast - 30 Days FREE Trial $37M 4,0x 0,3x
BANR Unlock Forecast - 30 Days FREE Trial $2299M 12,6x 1,2x
BCML Unlock Forecast - 30 Days FREE Trial $328M 13,6x 1,0x
BFST Unlock Forecast - 30 Days FREE Trial $723M 9,4x 0,9x
BHB Unlock Forecast - 30 Days FREE Trial $498M 12,6x 1,1x
BK Unlock Forecast - 30 Days FREE Trial $78106M 15,7x 1,8x
BK-PK Unlock Forecast - 30 Days FREE Trial $18624M 3,7x 0,4x
BKSC Unlock Forecast - 30 Days FREE Trial $87M 13,4x 2,1x
BMRC Unlock Forecast - 30 Days FREE Trial $398M 57,6x 0,9x
BMTX Unlock Forecast - 30 Days FREE Trial $58M -4,5x 2,7x
BOH Unlock Forecast - 30 Days FREE Trial $2713M 15,9x 1,6x
BOH-PA Unlock Forecast - 30 Days FREE Trial $699M 4,1x 0,4x
BOH-PB Unlock Forecast - 30 Days FREE Trial $1070M 6,3x 0,6x
BOTJ Unlock Forecast - 30 Days FREE Trial $70M 9,8x 1,0x
BPOP Unlock Forecast - 30 Days FREE Trial $8481M 11,8x 1,4x
BPOPM Unlock Forecast - 30 Days FREE Trial $1734M 2,4x 0,3x
BPOPO Unlock Forecast - 30 Days FREE Trial $1712M 2,4x 0,3x
BPRN Unlock Forecast - 30 Days FREE Trial $221M 32,3x 0,8x
BRBS Unlock Forecast - 30 Days FREE Trial $358M -1,3x 1,0x
BSRR Unlock Forecast - 30 Days FREE Trial $413M 10,2x 1,2x
BSVN Unlock Forecast - 30 Days FREE Trial $460M 10,4x 2,0x
BUSE Unlock Forecast - 30 Days FREE Trial $2194M 13,3x 1,0x
BWB Unlock Forecast - 30 Days FREE Trial $466M 12,3x 1,0x
BWBBP Unlock Forecast - 30 Days FREE Trial $549M 14,5x 1,2x
BWFG Unlock Forecast - 30 Days FREE Trial $359M 17,2x 1,3x
BY Unlock Forecast - 30 Days FREE Trial $1332M 11,2x 1,1x
CATY Unlock Forecast - 30 Days FREE Trial $3460M 11,7x 1,2x
CBAN Unlock Forecast - 30 Days FREE Trial $304M 11,0x 1,0x
CBFV Unlock Forecast - 30 Days FREE Trial $179M 15,5x 1,2x
CBSH Unlock Forecast - 30 Days FREE Trial $7525M 15,4x 3,1x
CCB Unlock Forecast - 30 Days FREE Trial $1664M 35,0x 3,6x
CCBG Unlock Forecast - 30 Days FREE Trial $739M 12,7x 1,4x
CCFN Unlock Forecast - 30 Days FREE Trial $178M 8,7x 1,0x
CCNE Unlock Forecast - 30 Days FREE Trial $540M 9,9x 0,9x
CCNEP Unlock Forecast - 30 Days FREE Trial $523M 9,6x 0,8x
CFB Unlock Forecast - 30 Days FREE Trial $0M 12,2x 0,0x
CFFI Unlock Forecast - 30 Days FREE Trial $228M 9,3x 1,0x
CFG Unlock Forecast - 30 Days FREE Trial $22767M 14,3x 0,9x
CFG-PE Unlock Forecast - 30 Days FREE Trial $8985M 5,6x 0,4x
CFG-PH Unlock Forecast - 30 Days FREE Trial $11779M 7,4x 0,5x
CHMG Unlock Forecast - 30 Days FREE Trial $252M 22,5x 1,1x
CIVB Unlock Forecast - 30 Days FREE Trial $0M 10,8x 0,0x
CNOB Unlock Forecast - 30 Days FREE Trial $1262M 33,7x 0,8x
CNOBP Unlock Forecast - 30 Days FREE Trial $1181M 31,5x 0,8x
COFS Unlock Forecast - 30 Days FREE Trial $455M 32,2x 1,1x
COLB Unlock Forecast - 30 Days FREE Trial $5478M 10,4x 1,0x
COSO Unlock Forecast - 30 Days FREE Trial $248M x 1,2x
CPF Unlock Forecast - 30 Days FREE Trial $831M 13,7x 1,5x
CSBB Unlock Forecast - 30 Days FREE Trial $120M 9,4x 1,0x
CTBI Unlock Forecast - 30 Days FREE Trial $1030M 11,3x 1,3x
CUBB Unlock Forecast - 30 Days FREE Trial $693M 4,7x 0,4x
CUBI Unlock Forecast - 30 Days FREE Trial $2201M 14,9x 1,2x
CUBI-PF Unlock Forecast - 30 Days FREE Trial $815M 5,5x 0,4x
CVBF Unlock Forecast - 30 Days FREE Trial $2772M 13,6x 1,2x
CWBC Unlock Forecast - 30 Days FREE Trial $403M 15,3x 1,1x
CZFS Unlock Forecast - 30 Days FREE Trial $310M 9,8x 1,0x
CZNC Unlock Forecast - 30 Days FREE Trial $311M 11,5x 1,1x
EBMT Unlock Forecast - 30 Days FREE Trial $138M 10,9x 0,8x
EBTC Unlock Forecast - 30 Days FREE Trial $496M 14,6x 1,3x
EFSC Unlock Forecast - 30 Days FREE Trial $2253M 11,2x 1,2x
EFSCP Unlock Forecast - 30 Days FREE Trial $771M 3,8x 0,4x
EFSI Unlock Forecast - 30 Days FREE Trial $199M 25,2x 1,1x
EGBN Unlock Forecast - 30 Days FREE Trial $615M -22,5x 0,5x
EMYB Unlock Forecast - 30 Days FREE Trial $133M 11,4x 1,2x
EQBK Unlock Forecast - 30 Days FREE Trial $735M 10,9x 1,2x
EWBC Unlock Forecast - 30 Days FREE Trial $15210M 12,8x 1,9x
FBIZ Unlock Forecast - 30 Days FREE Trial $431M 9,1x 1,3x
FBK Unlock Forecast - 30 Days FREE Trial $2470M 27,3x 1,5x
FBNC Unlock Forecast - 30 Days FREE Trial $2289M 23,6x 1,5x
FBP Unlock Forecast - 30 Days FREE Trial $3539M 11,5x 1,9x
FCBC Unlock Forecast - 30 Days FREE Trial $684M 13,7x 1,4x
FCCO Unlock Forecast - 30 Days FREE Trial $217M 12,6x 1,4x
FCNCA Unlock Forecast - 30 Days FREE Trial $26473M 11,0x 1,2x
FCNCB Unlock Forecast - 30 Days FREE Trial $22320M 9,3x 1,0x
FCNCO Unlock Forecast - 30 Days FREE Trial $307M 0,1x 0,0x
FCNCP Unlock Forecast - 30 Days FREE Trial $294M 0,1x 0,0x
FFIC Unlock Forecast - 30 Days FREE Trial $476M 19,5x 0,7x
FFIN Unlock Forecast - 30 Days FREE Trial $5165M 21,0x 3,0x
FFNW Unlock Forecast - 30 Days FREE Trial $208M 81,8x 1,3x
FFWM Unlock Forecast - 30 Days FREE Trial $493M -23,9x 0,5x
FHB Unlock Forecast - 30 Days FREE Trial $3234M 13,1x 1,2x
FIBK Unlock Forecast - 30 Days FREE Trial $3427M 14,9x 1,0x
FINW Unlock Forecast - 30 Days FREE Trial $260M 19,2x 1,4x
FITB Unlock Forecast - 30 Days FREE Trial $30721M 13,2x 1,5x
FITBI Unlock Forecast - 30 Days FREE Trial $17315M 7,4x 0,8x
FITBO Unlock Forecast - 30 Days FREE Trial $13960M 6,0x 0,7x
FITBP Unlock Forecast - 30 Days FREE Trial $16748M 7,2x 0,8x
FKYS Unlock Forecast - 30 Days FREE Trial $107M 13,8x 1,0x
FMBH Unlock Forecast - 30 Days FREE Trial $945M 11,2x 1,1x
FMBM Unlock Forecast - 30 Days FREE Trial $87M 10,3x 0,9x
FMNB Unlock Forecast - 30 Days FREE Trial $554M 11,0x 1,3x
FRAF Unlock Forecast - 30 Days FREE Trial $212M 14,6x 1,3x
FRST Unlock Forecast - 30 Days FREE Trial $294M -22,0x 0,8x
FSBC Unlock Forecast - 30 Days FREE Trial $701M 13,5x 1,7x
FUSB Unlock Forecast - 30 Days FREE Trial $76M 9,8x 0,7x
FVCB Unlock Forecast - 30 Days FREE Trial $227M 12,0x 0,9x
FXNC Unlock Forecast - 30 Days FREE Trial $210M 26,3x 1,2x
GABC Unlock Forecast - 30 Days FREE Trial $1534M 17,8x 1,4x
GBCI Unlock Forecast - 30 Days FREE Trial $5799M 26,3x 1,6x
GBFH Unlock Forecast - 30 Days FREE Trial $571M x 3,8x
GLBZ Unlock Forecast - 30 Days FREE Trial $16M 28,2x 0,8x
GNRV Unlock Forecast - 30 Days FREE Trial $7M x 0,7x
GSBC Unlock Forecast - 30 Days FREE Trial $724M 10,6x 1,2x
HBIA Unlock Forecast - 30 Days FREE Trial $747M 13,3x 1,5x
HBNC Unlock Forecast - 30 Days FREE Trial $715M 13,8x 0,9x
HBT Unlock Forecast - 30 Days FREE Trial $808M 10,5x 1,4x
HMST Unlock Forecast - 30 Days FREE Trial $262M -13,1x 0,7x
HNVR Unlock Forecast - 30 Days FREE Trial $163M 14,3x 0,8x
HOMB Unlock Forecast - 30 Days FREE Trial $5923M 15,8x 1,5x
HONE Unlock Forecast - 30 Days FREE Trial $562M 21,3x 1,0x
HTBK Unlock Forecast - 30 Days FREE Trial $627M 16,0x 0,9x
HTH Unlock Forecast - 30 Days FREE Trial $2250M 15,7x 1,0x
HTLF Unlock Forecast - 30 Days FREE Trial $0M 33,6x 0,0x
HTLFP Unlock Forecast - 30 Days FREE Trial $0M 12,6x 0,0x
HWC Unlock Forecast - 30 Days FREE Trial $5450M 13,1x 1,3x
HWCPZ Unlock Forecast - 30 Days FREE Trial $2067M 5,5x 0,5x
IBCP Unlock Forecast - 30 Days FREE Trial $1330M 20,5x 2,8x
IBOC Unlock Forecast - 30 Days FREE Trial $4396M 10,7x 1,5x
IBTX Unlock Forecast - 30 Days FREE Trial $2514M -8,0x 1,3x
INBK Unlock Forecast - 30 Days FREE Trial $214M 13,9x 0,6x
INBKZ Unlock Forecast - 30 Days FREE Trial $218M 14,1x 0,6x
INDB Unlock Forecast - 30 Days FREE Trial $3038M 16,1x 1,0x
ISBA Unlock Forecast - 30 Days FREE Trial $241M 14,8x 1,1x
ISTR Unlock Forecast - 30 Days FREE Trial $225M 10,1x 0,9x
JMSB Unlock Forecast - 30 Days FREE Trial $286M 15,1x 1,1x
LKFN Unlock Forecast - 30 Days FREE Trial $1677M 17,7x 2,4x
LNKB Unlock Forecast - 30 Days FREE Trial $274M 71,1x 1,0x
LOB Unlock Forecast - 30 Days FREE Trial $1681M 30,0x 1,6x
MBCN Unlock Forecast - 30 Days FREE Trial $246M 13,5x 1,1x
MBIN Unlock Forecast - 30 Days FREE Trial $1499M 5,9x 0,7x
MBINL Unlock Forecast - 30 Days FREE Trial $1070M 4,2x 0,5x
MBINM Unlock Forecast - 30 Days FREE Trial $1166M 4,6x 0,5x
MBINN Unlock Forecast - 30 Days FREE Trial $945M 3,7x 0,4x
MBINO Unlock Forecast - 30 Days FREE Trial $1144M 4,0x 0,6x
MBWM Unlock Forecast - 30 Days FREE Trial $775M 9,5x 1,2x
MCB Unlock Forecast - 30 Days FREE Trial $850M 12,4x 1,2x
MCBS Unlock Forecast - 30 Days FREE Trial $745M 11,3x 1,7x
MNSB Unlock Forecast - 30 Days FREE Trial $167M 11,1x 0,8x
MNSBP Unlock Forecast - 30 Days FREE Trial $183M 13,3x 0,9x
MOFG Unlock Forecast - 30 Days FREE Trial $608M -84,8x 1,0x
MPB Unlock Forecast - 30 Days FREE Trial $689M 15,6x 0,9x
MSBI Unlock Forecast - 30 Days FREE Trial $394M 7,4x 0,5x
MSBIP Unlock Forecast - 30 Days FREE Trial $514M 9,7x 0,6x
MTB Unlock Forecast - 30 Days FREE Trial $32307M 12,0x 1,1x
MTB-PH Unlock Forecast - 30 Days FREE Trial $4029M 1,5x 0,1x
MTB-PJ Unlock Forecast - 30 Days FREE Trial $4375M 1,6x 0,2x
MVBF Unlock Forecast - 30 Days FREE Trial $315M 18,4x 1,0x
MYFW Unlock Forecast - 30 Days FREE Trial $230M 19,9x 0,9x
NPB Unlock Forecast - 30 Days FREE Trial $624M x 1,0x
NTRS Unlock Forecast - 30 Days FREE Trial $25204M 14,5x 2,0x
NTRSO Unlock Forecast - 30 Days FREE Trial $4014M 2,3x 0,3x
NWFL Unlock Forecast - 30 Days FREE Trial $244M 77,0x 1,1x
NWPP Unlock Forecast - 30 Days FREE Trial $75M 8,2x 1,0x
OBK Unlock Forecast - 30 Days FREE Trial $1111M 15,9x 0,9x
OBT Unlock Forecast - 30 Days FREE Trial $348M 11,8x 1,4x
OFG Unlock Forecast - 30 Days FREE Trial $1981M 10,2x 1,5x
OPBK Unlock Forecast - 30 Days FREE Trial $215M 9,7x 1,0x
ORRF Unlock Forecast - 30 Days FREE Trial $688M 15,9x 1,3x
OSBC Unlock Forecast - 30 Days FREE Trial $836M 10,0x 1,2x
OVBC Unlock Forecast - 30 Days FREE Trial $0M 7,7x 0,0x
OVLY Unlock Forecast - 30 Days FREE Trial $244M 10,1x 1,3x
PB Unlock Forecast - 30 Days FREE Trial $6464M 12,4x 0,9x
PBHC Unlock Forecast - 30 Days FREE Trial $84M 12,4x 0,7x
PCB Unlock Forecast - 30 Days FREE Trial $309M 9,8x 0,8x
PEBK Unlock Forecast - 30 Days FREE Trial $172M 10,1x 1,2x
PEBO Unlock Forecast - 30 Days FREE Trial $1070M 10,3x 0,9x
PFBX Unlock Forecast - 30 Days FREE Trial $92M 4,7x 1,0x
PFC Unlock Forecast - 30 Days FREE Trial $1038M 13,2x 1,0x
PKBK Unlock Forecast - 30 Days FREE Trial $270M 8,7x 0,9x
PMHG Unlock Forecast - 30 Days FREE Trial $171M 21,0x 1,9x
PPBI Unlock Forecast - 30 Days FREE Trial $2376M 17,2x 0,8x
PWOD Unlock Forecast - 30 Days FREE Trial $244M 14,7x 1,5x
QCRH Unlock Forecast - 30 Days FREE Trial $1306M 11,6x 1,2x
QNBC Unlock Forecast - 30 Days FREE Trial $132M 10,3x 1,2x
RBB Unlock Forecast - 30 Days FREE Trial $343M 14,9x 0,7x
RBCAA Unlock Forecast - 30 Days FREE Trial $1501M 12,1x 1,4x
RMBI Unlock Forecast - 30 Days FREE Trial $151M 15,8x 1,1x
RNST Unlock Forecast - 30 Days FREE Trial $3679M 23,0x 1,0x
RRBI Unlock Forecast - 30 Days FREE Trial $427M 13,0x 1,3x
RVRF Unlock Forecast - 30 Days FREE Trial $272M 7,1x 1,1x
SBCF Unlock Forecast - 30 Days FREE Trial $2654M 19,1x 1,2x
SBFG Unlock Forecast - 30 Days FREE Trial $8M 10,8x 0,1x
SBSI Unlock Forecast - 30 Days FREE Trial $926M 10,8x 1,2x
SFBS Unlock Forecast - 30 Days FREE Trial $4576M 18,3x 2,7x
SFDL Unlock Forecast - 30 Days FREE Trial $98M 8,4x 0,5x
SLBK Unlock Forecast - 30 Days FREE Trial $101M 9,3x 1,0x
SPFI Unlock Forecast - 30 Days FREE Trial $676M 12,4x 1,5x
SRCE Unlock Forecast - 30 Days FREE Trial $1631M 11,6x 1,4x
SSB Unlock Forecast - 30 Days FREE Trial $10311M 17,4x 1,2x
SSBK Unlock Forecast - 30 Days FREE Trial $361M 10,6x 1,2x
STBA Unlock Forecast - 30 Days FREE Trial $1499M 12,4x 1,1x
STT Unlock Forecast - 30 Days FREE Trial $32787M 11,5x 1,2x
STT-PG Unlock Forecast - 30 Days FREE Trial $6765M 2,4x 0,3x
SYBT Unlock Forecast - 30 Days FREE Trial $2268M 17,7x 2,3x
TCBI Unlock Forecast - 30 Days FREE Trial $4036M 30,1x 1,2x
TCBIO Unlock Forecast - 30 Days FREE Trial $954M 7,1x 0,3x
TCBK Unlock Forecast - 30 Days FREE Trial $1500M 13,4x 1,2x
TECTP Unlock Forecast - 30 Days FREE Trial $74M 4,5x 0,6x
TFIN Unlock Forecast - 30 Days FREE Trial $1402M 103,0x 1,5x
TFINP Unlock Forecast - 30 Days FREE Trial $522M 38,3x 0,6x
THFF Unlock Forecast - 30 Days FREE Trial $664M 12,1x 1,2x
TMP Unlock Forecast - 30 Days FREE Trial $0M 47,6x 0,0x
TRST Unlock Forecast - 30 Days FREE Trial $752M 14,1x 1,1x
UBCP Unlock Forecast - 30 Days FREE Trial $82M 9,3x 1,4x
UBSI Unlock Forecast - 30 Days FREE Trial $5332M 13,5x 1,0x
UCB Unlock Forecast - 30 Days FREE Trial $3936M 14,4x 1,1x
UCB-PI Unlock Forecast - 30 Days FREE Trial $3033M 11,1x 0,8x
UNB Unlock Forecast - 30 Days FREE Trial $0M 16,5x 0,0x
UNTY Unlock Forecast - 30 Days FREE Trial $531M 10,5x 1,7x
USCB Unlock Forecast - 30 Days FREE Trial $0M -3,5x 0,0x
UVSP Unlock Forecast - 30 Days FREE Trial $897M 11,2x 1,0x
UWHR Unlock Forecast - 30 Days FREE Trial $84M 8,3x 1,5x
VBFC Unlock Forecast - 30 Days FREE Trial $120M 56,1x 1,6x
VBTX Unlock Forecast - 30 Days FREE Trial $3760M 32,5x 2,3x
WAL Unlock Forecast - 30 Days FREE Trial $10098M 11,9x 1,4x
WAL-PA Unlock Forecast - 30 Days FREE Trial $2587M 3,1x 0,4x
WASH Unlock Forecast - 30 Days FREE Trial $579M 13,8x 1,1x
WTBA Unlock Forecast - 30 Days FREE Trial $344M 11,9x 1,4x
WTFC Unlock Forecast - 30 Days FREE Trial $9183M 12,4x 1,3x
WTFCM Unlock Forecast - 30 Days FREE Trial $1807M 2,6x 0,3x
WTFCN Unlock Forecast - 30 Days FREE Trial $1811M 2,5x 0,3x
WTFCP Unlock Forecast - 30 Days FREE Trial $1814M 2,6x 0,3x

Preguntas frecuentes - Live Oak Bancshares, Inc. Previsión de existencias

¿Hasta qué punto son precisas las predicciones bursátiles de Live Oak Bancshares, Inc.?

Our AI model demonstrates 74% historical accuracy for LOB predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

¿Qué factores influyen en las previsiones Live Oak Bancshares, Inc. del precio de las acciones?

Nuestro análisis tiene en cuenta las métricas financieras de Live Oak Bancshares, Inc., las tendencias del sector Finance, el sentimiento del mercado, los indicadores técnicos, los datos de beneficios y los factores macroeconómicos que afectan al rendimiento de las acciones.

¿Es Live Oak Bancshares, Inc. una buena inversión en 2025?

Según nuestro análisis de IA, Live Oak Bancshares, Inc. muestra potencial para diversos escenarios de mercado. Considere su tolerancia al riesgo, el plazo de inversión y la diversificación de la cartera antes de tomar decisiones de inversión.

¿Con qué frecuencia se actualizan las previsiones Live Oak Bancshares, Inc.?

Las previsiones bursátiles de Live Oak Bancshares, Inc. se actualizan a diario utilizando datos de mercado en tiempo real, lo que garantiza que reciba las predicciones y perspectivas de inversión más actuales basadas en IA.

¿Desea un análisis Live Oak Bancshares, Inc. más avanzado?

Desbloquee las funciones premium, incluidos los objetivos de precios detallados, las evaluaciones de riesgo, la optimización de la cartera y las alertas en tiempo real para las acciones Live Oak Bancshares, Inc..

🎯 Análisis Premium 📊 Más acciones

Mi cartera

Panel de inversiones

Cargando su cartera...